Wealth Shield Partners, LLC Amgen Inc Transaction History

Wealth Shield Partners, LLC

$721 Million
Q3 2024

A detailed history of Wealth Shield Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Wealth Shield Partners, LLC holds 9,421 shares of AMGN stock, worth $2.49 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

9,421

Previous 4,969 89.6%

Holding current value

$2.49 Million

Previous $1.55 Million 95.55%

% of portfolio

0.42%

Previous 0.24%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$309.38 - $337.38 $1.38 Million - $1.5 Million	4,452 Added 89.6%	9,421 $3.04 Million
Q2 2024 Jul 26, 2024	SELL	$262.75 - $319.31 $872,855 - $1.06 Million	-3,322 Reduced 40.07%	4,969 $1.55 Million
Q1 2024 Apr 29, 2024	BUY	$268.87 - $324.56 $546,881 - $660,155	2,034 Added 32.51%	8,291 $2.36 Million
Q4 2023 Jan 23, 2024	BUY	$255.7 - $288.46 $845,599 - $953,937	3,307 Added 112.1%	6,257 $1.8 Million
Q3 2023 Oct 25, 2023	BUY	$218.65 - $271.46 $645,017 - $800,806	2,950 New	2,950 $792,000
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $44,788 - $52,475	-211 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$233.58 - $259.14 $282,398 - $313,300	-1,209 Reduced 85.14%	211 $51,000
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $443 - $517	2 Added 0.14%	1,420 $353,000
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $101,698 - $121,104	470 Added 49.58%	1,418 $326,000
Q3 2020 Oct 30, 2020	BUY	$234.65 - $260.95 $16,660 - $18,527	71 Added 8.1%	948 $241,000
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $173,479 - $212,882	877 New	877 $207,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Shield Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Shield Partners, LLC with notifications on news.

Account

Wealth Shield Partners, LLC Amgen Inc Transaction History